ERBB2 and breast cancer: Similarly, deleting Elf5 in the MMTV-neu (HER2) background increased EMT markers and the formation of lung metastases [51], while transgenic overexpression of Elf5 in the MMTV-PyMT model of luminal breast cancer inhibited cell proliferation [57].